UBD and melanoma: As shown in Figure 7A, elevated UBD expression was significantly associated with improved OS in breast cancer (BRCA; p=0.009, HR = 0.949) and exerted a protective effect in melanoma (SKCM; p<0.001, HR = 0.891) and sarcoma (SARC; p=0.006, HR = 0.899).